These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16790814)

  • 1. Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.
    Murray HW; Tsai CW; Liu J; Ma X
    Infect Immun; 2006 Jul; 74(7):4370-4. PubMed ID: 16790814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral Leishmania donovani infection in interleukin-13-/- mice.
    Murray HW; Tsai CW; Liu J; Ma X
    Infect Immun; 2006 Apr; 74(4):2487-90. PubMed ID: 16552085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
    Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
    J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.
    Stäger S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM
    Eur J Immunol; 2006 Jul; 36(7):1764-71. PubMed ID: 16791879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
    Murray HW; Mitchell-Flack M; Zheng H; Ma X
    Infect Immun; 2015 Feb; 83(2):702-12. PubMed ID: 25452549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.
    Murray HW
    Infect Immun; 2008 Sep; 76(9):4088-91. PubMed ID: 18573898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.
    Khader SA; Pearl JE; Sakamoto K; Gilmartin L; Bell GK; Jelley-Gibbs DM; Ghilardi N; deSauvage F; Cooper AM
    J Immunol; 2005 Jul; 175(2):788-95. PubMed ID: 16002675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.
    Maroof A; Kaye PM
    Infect Immun; 2008 Jan; 76(1):239-49. PubMed ID: 17998312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.
    Murray HW; Hariprashad J; Coffman RL
    J Exp Med; 1997 Mar; 185(5):867-74. PubMed ID: 9120392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
    Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
    J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae.
    Happel KI; Dubin PJ; Zheng M; Ghilardi N; Lockhart C; Quinton LJ; Odden AR; Shellito JE; Bagby GJ; Nelson S; Kolls JK
    J Exp Med; 2005 Sep; 202(6):761-9. PubMed ID: 16157683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.